Induction of angiogenesis during the transition from hyperplasia to neoplasia

Cited by (1,001)

Items 201–300 of 1,001

1. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II.
   Chang Y. Chung, Joanne E. Murphy-Ullrich, Harold Erickson · 1996 · Molecular Biology of the Cell
2. Vascular Endothelial Growth Factor 189 mRNA Isoform Expression Specifically Correlates With Tumor Angiogenesis, Patient Survival, and Postoperative Relapse in Non–Small-Cell Lung Cancer
   Ang Yuan, Chong‐Jen Yu, Sow-Hsong Kuo, Wen‐Jone Chen, Fang‐Yue Lin, Kwen‐Tay Luh, Pan‐Chyr Yang, Yung-Chie Lee · 2001 · Journal of Clinical Oncology
3. Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures
   Romano Demicheli, Michael W Retsky, William J.M. Hrushesky, Michael Baum · 2007 · Nature Clinical Practice Oncology
4. A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics
   Anguraj Sadanandam, Stephan Wullschleger, Costas Andreas Lyssiotis, Carsten Grötzinger, Stefano Barbi, Samantha Bersani, Jan Körner, Ismael Wafy, Andrea Mafficini, Rita T. Lawlor et al. · 2015 · Cancer Discovery
5. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer
   Wolfgang Hilbe, Stefan Dirnhofer, Frieda Oberwasserlechner, Thomas A. Schmid, Eberhard Gunsilius, G Hilbe, Ewald Wöll, C M Kähler · 2004 · Journal of Clinical Pathology
6. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma.
   Robert K. Vartanian, Noel Weidner · 1994 · PubMed Central
7. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.
   Paul Naik, Juliana Karrim, Douglas Hanahan · 1996 · Genes & Development
8. Growth factor messenger RNA expression by human breast fibroblasts from benign and malignant lesions.
   Kevin J. Cullen, Helene S. Smith, Steven M. Hill, Neal X. Rosen, M. E. Lippman · 1991 · PubMed
9. Benign versus Malignant Breast Masses: Optical Differentiation with US-guided Optical Imaging Reconstruction
   Quing Zhu, Edward Cronin, Allen A. Currier, Hugh S. Vine, Minming Huang, Nanguang Chen, Xu Chen · 2005 · Radiology
10. Assays for angiogenesis: A review
    Robert Auerbach, Wanda Auerbach, Igor J. Polakowski · 1991 · Pharmacology & Therapeutics
11. Pathologic diagnosis as the gold standard
    LUCY BALIAN RORKE · 1997 · Cancer
12. Reciprocal paracrine interactions between tumour cells and endothelial cells: the ‘angiogenesis progression’ hypothesis
    Janusz W. Rak, Jorge Filmus, Robert S. Kerbel · 1996 · European Journal of Cancer
13. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
    Ksenya Shchors, Elena Shchors, Fanya Rostker, Elizabeth R. Lawlor, Lamorna Brown Swigart, Gérard I. Evan · 2006 · Genes & Development
14. Efficacy of capillary pattern type IIIA/IIIB by magnifying narrow band imaging for estimating depth of invasion of early colorectal neoplasms
    Hiroaki Ikematsu, Takahisa Matsuda, Fabián Emura, Yutaka Saito, Toshio Uraoka, Kuang‐I Fu, Kazuhiro Kaneko, Atsushi Ochiai, Takahiro Fujimori, Yasushi Sano · 2010 · BMC Gastroenterology
15. Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor.
    P. Charles Lin, Sabita Sankar, Si Qing Shan, Mark W. Dewhirst, Peter J. Polverini, Timothy Q. Quinn, Kevin G. Peters · 1998 · PubMed
16. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo
    Raymond A. Sawaya, Masaaki Yamamoto, Ziya L. Gokaslan, Shang Wu Wang, Sanjeeva Mohanam, Gregory N. Fuller, Ian E. McCutcheon, William George Stetler‐Stevenson, Garth L. Nicolson, Jasti Sambasiva Rao · 1996 · Clinical & Experimental Metastasis
17. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma
    Akihiro Imada, Noriharu Shijubo, Hayato Kojima, Shosaku Abe · 2000 · European Respiratory Journal
18. Angiogenesis: Models and Modulators
    GILLIAN W. COCKERILL, Jennifer R. Gamble, Mathew Alexander Vadas · 1995 · International review of cytology
19. Vascular remodeling in cancer
    Rae H. Farnsworth, Martin Lackmann, Marc G. Achen, Steven A. Stacker · 2013 · Oncogene
20. Angiogenic growth factors.
    Risau, Werner · 1990 · Progress in Growth Factor Research
21. High Expression of Vascular Endothelial Growth Factor Predicts Early Recurrence and Poor Prognosis after Curative Resection for Ductal Adenocarcinoma of the Pancreas
    Marco Niedergethmann, Ralf Hildenbrand, Birgit Wostbrock, Mark Hartel, Jörg W. Sturm, Axel Richter, Stefan Post · 2002 · Pancreas
22. Prognostic factors in early breast carcinoma
    Edward G. Mansour, Peter M. Ravdin, Lynn G. Dressier · 1994 · Cancer
23. De novo expression of vascular endothelial growth factor in human pancreatic cancer: Evidence for an autocrine mitogenic loop
    Zofia von Marschall, Thorsten Cramer, Michael R. Höcker, Rahel Burde, Thomas Plath, Michael Schirner, Regina Heidenreich, Georg Breier, Ernst–Otto Riecken, Bertram Wiedenmann et al. · 2000 · Gastroenterology
24. p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2–stimulated angiogenesis
    Tarô Matsumoto, Ingela Turesson, Majlis Book, Pär Gerwins, Lena Claesson · 2002 · The Journal of Cell Biology
25. Does surgery unfavourably perturb the “natural history” of early breast cancer by accelerating the appearance of distant metastases?
    Michael Baum, Romano Demicheli, William J.M. Hrushesky, Michael W Retsky · 2005 · European Journal of Cancer
26. Microvessel count predicts metastatic disease and survival in non‐small cell lung cancer
    Gabriella Fontanini, Daniela Bigini, Silvana Vignati, Fulvio Basolo, Alfredo Mussi, Marco Lucchi, S Chinè, Carlo Alberto Angeletti, Adrian Llewellyn Harris, Generoso Bevilacqua · 1995 · The Journal of Pathology
27. Pivotal role for decorin in angiogenesis
    Hannu Järveläinen, Annele Sainio, Thomas N. Wight · 2015 · Matrix Biology
28. Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma
    Zofia von Marschall, Thorsten Cramer, Michael R. Höcker, G Finkenzeller, Bertram Wiedenmann, S Rosewicz · 2001 · Gut
29. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition
    Benoît Thibault, Magali Castells, Jean‐Pierre Delord, Bettina C. Couderc · 2013 · Cancer and Metastasis Reviews
30. Hypoxia‐inducible factor‐1α is associated with angiogenesis, and expression of bFGF, PDGF‐BB, and EGFR in invasive breast cancer
    Reinhard Bos, P. J. van Diest, Johannes S. de Jong, Paul van der Valk, Petra van der Groep, Elsken van der Wall · 2005 · Histopathology
31. The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review
    Doménico Ribatti · 2005 · British Journal of Haematology
32. Chemokines: novel targets for breast cancer metastasis
    Simi Ali, Gwendal Lazennec · 2007 · Cancer and Metastasis Reviews
33. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer
    Kaisa Lehtiö, Olli Eskola, Tapio Viljanen, Vesa Oikonen, Tove J. Grönroos, Lauri H. Sillanmäki, Reidar A. Grenman, Heikki R. I. Minn · 2004 · International Journal of Radiation Oncology*Biology*Physics
34. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis.
    Yi Ren, Ronnie T. P. Poon, Hong‐Teng Tsui, Wen-Hong Chen, Zhi Li, Cecilia Pik-Yuk Lau, Wun‐Ching Yu, Sheung-Tat Fan · 2003 · PubMed
35. Endogenous Myc maintains the tumor microenvironment
    Nicole M. Sodir, Lamorna Brown Swigart, Anthony Nicholas Karnezis, Douglas Hanahan, Gérard I. Evan, Laura Soucek · 2011 · Genes & Development
36. Up-regulation of hypoxia-inducible factor 1α is an early event in prostate carcinogenesis
    Hua Zhong, Gregg L. Semenza, Jonathan W. Simons, Angelo Michael De Marzo · 2004 · Cancer Detection and Prevention
37. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer
    Douglas Hanahan, Erwin Friedrich Wagner, Richard D. Palmiter · 2007 · Genes & Development
38. CD34 IMMUNOHISTOCHEMICAL ASSESSMENT OF ANGIOGENESIS AS A PROGNOSTIC MARKER FOR PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY
    Marie‐Claude Bettencourt, John J. Bauer, Isabella A. Sesterhenn, Roger R. Connelly, Judd W. Moul · 1998 · The Journal of Urology
39. Mechanistic considerations in chemopreventive drug development
    Gary J. Kelloff, Charles W. Boone, Vernon E. Steele, Judith R. Fay, Ronald A. Lubet, James A. Crowell, Caroline C. Sigman · 1994 · Journal of Cellular Biochemistry
40. Immunoreactivity for Thyroid Transcription Factor-1 in Stage I Non–Small Cell Carcinomas of the Lung
    Giuseppe Pelosi, Filippo Fraggetta, Felice Pasini, Patrick Maisonneuve, Angelica Sonzogni, Antonio Iannucci, Alberto Claudio Terzi, Enrica Bresaola, Francesco Valduga, Carmelo Lupo et al. · 2001 · The American Journal of Surgical Pathology
41. A Potential Role for Interleukin-8 in the Metastatic Phenotype of Breast Carcinoma Cells
    Joseph E. De Larco, Beverly R. K. Wuertz, Karen A. Rosner, Steven A. Erickson, David E. Gamache, Juan Carlos Manivel, Leo T. Furcht · 2001 · American Journal Of Pathology
42. Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma
    Hideyuki Imoto, Toshihiro Osaki, Satoshi Taga, Akira Ohgami, Yuji Ichiyoshi, Kosei Yasumoto · 1998 · Journal of Thoracic and Cardiovascular Surgery
43. Angiogenesis in epithelian ovarian cancer
    E S Bamberger, Christopher W. Perrett · 2002 · Molecular Pathology
44. Angiogenesis spectrum in the stroma of B‐cell non‐Hodgkin's lymphomas. An immunohistochemical and ultrastructural study
    Doménico Ribatti, Angelo Vacca, Beatrice Nico, Massimo Fanelli, Luisa Roncali, Franco Dammacco · 1996 · European Journal Of Haematology
45. Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
    Iris Helfrich, Inka Scheffrahn, Sönke H. Bartling, Joachim Weis, Verena von Felbert, Mark Ross Middleton, Masahi Kato, Süleyman Ergün, Hellmut G. Augustin, Dirk Schadendorf · 2010 · The Journal of Experimental Medicine
46. The role of lysosomes in cancer development and progression
    Tao Tang, Zeyu Yang, Di Wang, Xianyan Yang, Jun Wang, Lin Li, Qian Wen, Lei Gao, Xiu‐Wu Bian, Shi‐Cang Yu · 2020 · Cell & Bioscience
47. Stimulation of angiogenesis by Ras proteins
    Onno Kranenburg, Martijn F.B.G. Gebbink, Emile E. Voest · 2003 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
48. The Role of the Vascular Phase in Solid Tumor Growth: A Historical Review
    Doménico Ribatti, Angelo Vacca, Franco Dammacco · 1999 · Neoplasia
49. The challenges facing block copolymer micelles for cancer therapy: In vivo barriers and clinical translation
    Sina Eetezadi, Sandra N. Ekdawi, Christine J. Allen · 2014 · Advanced Drug Delivery Reviews
50. Role of the nervous system in cancers: a review
    Huan Wang, Qiming Zheng, Zeyi Lu, Liya Wang, Lifeng Ding, Liqun Xia, Hao Zhang, Mingchao Wang, Yi-Cheng Chen, Gonghui Li · 2021 · Cell Death Discovery
51. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus.
    Chih-Horng Shih, Soji Ozawa, N Ando, Mitsuharu Ueda, Masaki Kitajima · 2000 · PubMed
52. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer
    Joyce, Johanna A, Freeman, Craig, Meyer-Morse, Nicole, Parish, Christopher R, Hanahan, Douglas · 2005 · Oncogene
53. Cancer as a disease of epithelial–mesenchymal interactions and extracellular matrix regulation
    Donald E. Ingber · 2002 · Differentiation
54. Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells.
    Napoleone Ferrara, Jane Winer, Theresa Burton, Ann M. Rowland, M Siegel, HEIDI S. PHILLIPS, T Terrell, G A Keller, Arthur D. Levinson · 1993 · Journal of Clinical Investigation
55. Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
    Iris Helfrich, Inka Scheffrahn, Sönke H. Bartling, Joachim Weis, Verena von Felbert, Mark Ross Middleton, Masahi Kato, Süleyman Ergün, Hellmut G. Augustin, Dirk Schadendorf · 2013 · The Journal of Experimental Medicine
56. Antiproliferative, antiangiogenic and proapoptotic activity of h‐R3: A humanized anti‐EGFR antibody
    Tania Crombet, Janusz W. Rak, Rolando Pérez, Alicia Viloria‐Petit · 2002 · International Journal of Cancer
57. Directional control of cell motility through focal adhesion positioning and spatial control of Rac activation
    Nan Xia, Charles Kumar Thodeti, Tom P. Hunt, Qiaobing Xu, Madelyn Ho, George M. Whitesides, Robert M. Westervelt, Donald E. Ingber · 2008 · The FASEB Journal
58. Exosomes: Emerging biomarkers and targets for ovarian cancer
    Maggie K. S. Tang, Alice S.T. Wong · 2015 · Cancer Letters
59. A Non-Genetic Basis for Cancer Progression and Metastasis: Self-Organizing Attractors in Cell Regulatory Networks
    Sui Huang, Donald E. Ingber · 2007 · Breast Disease
60. Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: A morphometric study
    Kazuhiko Ueda, Tadashi Terada, Yasuni Nakanuma, Osamu Matsui · 1992 · Human Pathology
61. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
    R. Apolinario, Paul van der Valk, Johannes S. de Jong, W.L.J.M. Devillé, Jannette van Ark-Otte, Anne‐Marie C. Dingemans, Johan C. van Mourik, Pieter E. Postmus, Herbert M. Pinedo, Giuseppe Giaccone · 1997 · Journal of Clinical Oncology
62. Expression of CEACAM6 in Resectable Colorectal Cancer: A Factor of Independent Prognostic Significance
    Peter Jantscheff, Luigi Terracciano, Adam Lowy, Katharina Glatz‐Krieger, Fritz Grunert, Burkhard Micheel, Jens Brümmer, Urban Th. Laffer, Urs F. Metzger, Richard Herrmann et al. · 2003 · Journal of Clinical Oncology
63. Layilin, a Novel Integral Membrane Protein, Is a Hyaluronan Receptor
    Petri Bono, Kristofer Rubin, Jonathan M.G. Higgins, Richard O. Hynes · 2001 · Molecular Biology of the Cell
64. The cancer matrisome: From comprehensive characterization to biomarker discovery
    Alexandra M. Socovich, Alexandra Naba · 2018 · Seminars in Cell and Developmental Biology
65. Induction of Vascular Endothelial Growth Factor in Balloon-Injured Baboon Arteries
    Johannes Ruef, Zhao Y. Hu, Li-Yan Yin, Yaxu Wu, Stephen R. Hanson, Andrew B. Kelly, Laurence A. Harker, Gadiparthi N. Rao, Marschall S. Runge, Cam Patterson · 1997 · Circulation Research
66. Transvaginal ultrasonographic characterization of ovarian masses by means of color flow-directed Doppler measurements and a morphologic scoring system
    Ilan E. Timor‐Tritsch, Jodi P. Lerner, Ana Monteagudo, Ricardo Sousa-Santos · 1993 · American Journal of Obstetrics and Gynecology
67. Inducible Nitric Oxide Synthase Expression in Human Colorectal Cancer
    Fabio Cianchi, Camillo Cortesini, Ornella Fantappiè, Luca Messerini, Nicola Schiavone, Alfredo Vannacci, Silvia Nistri, Iacopo Sardi, Gianna Baroni, Cosimo Marzocca et al. · 2003 · American Journal Of Pathology
68. Sequential Hemodynamic Change in Hepatocellular Carcinoma and Dysplastic Nodules
    Tsuyoshi Tajima, Hiroshi Honda, Kenichi Taguchi, Yoshiki Asayama, Toshirou Kuroiwa, Kengo Yoshimitsu, Hiroyuki Irié, Hitoshi Aibe, Mitsuo Shimada, Kouji Masuda · 2002 · American Journal of Roentgenology
69. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors
    Anne-Marie Marion-Audibert, Cécile Barel, Géraldine Gouysse, Jérôme Dumortier, F. Pilleul, Céline Pourreyron, Valérie Hervieu, Gilles Poncet, Catherine Lombard‐Bohas, Jean‐Alain Chayvialle et al. · 2003 · Gastroenterology
70. Islet Vasculature as a Regulator of Endocrine Pancreas Function
    Nikiforos Ballian, Francis Charles Brunicardi · 2007 · World Journal of Surgery
71. Gene Expression of Angiogenic Factors Correlates with Metastatic Potential of Prostate Cancer Cells
    Ravikumar Aalinkeel, Madhavan Nair, Gerald Sufrin, Supriya D. Mahajan, Kailash C. Chadha, Ram P. Chawda, Stanley A. Schwartz · 2004 · Cancer Research
72. Vascular Endothelial Growth Factor Expression Is Higher in Differentiated Thyroid Cancer than in Normal or Benign Thyroid1
    Euy Young Soh, Quan‐Yang Duh, Saif Al Sobhi, Dave M. Young, Howard D. Epstein, Mariwil G. Wong, Y. Kit Garcia, Young D. Min, Richard F. Grossman, ALLAN E. SIPERSTEIN et al. · 1997 · The Journal of Clinical Endocrinology & Metabolism
73. Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo.
    Masaaki Yamamoto, Raymond A. Sawaya, S Mohanam, A K Bindal, J. M. Bruner, Kazunari Oka, Velidi H. Rao, Masamichi Tomonaga, Garth L. Nicolson, Jasti Sambasiva Rao · 1994 · PubMed
74. Tumor Angiogenesis as a Prognostic Predictor in Colorectal Carcinoma with Special Reference to Mode of Metastasis and Recurrence
    Hong Jo Choi, Moon Soo Hyun, Ghap Joong Jung, Sang Soon Kim, Sook Hee Hong · 1998 · Oncology
75. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma
    Alok A. Khorana, Charlotte Ryan, Christopher Cox, Shirley W. Eberly, Deepak M. Sahasrabudhe · 2003 · Cancer
76. The p53 family and the hypoxia-inducible factors (HIFs): determinants of cancer progression
    Ivano Amelio, Gerry Melino · 2015 · Trends in Biochemical Sciences
77. Tyrosine Residues 951 and 1059 of Vascular Endothelial Growth Factor Receptor-2 (KDR) Are Essential for Vascular Permeability Factor/Vascular Endothelial Growth Factor-induced Endothelium Migration and Proliferation, Respectively
    Huiyan Zeng, Sohini Sanyal, Debabrata Mukhopadhyay · 2001 · Journal of Biological Chemistry
78. Dynamic contrast‐enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti‐angiogenic therapy in a xenograft model of glioblastoma multiforme
    Axel Goßmann, Thomas H. Helbich, Nagato Kuriyama, Susanne Ostrowitzki, Timothy P. L. Roberts, David M. Shames, Nick van Bruggen, Michael F. Wendland, Mark A. Israel, Robert C. Brasch · 2002 · Journal of Magnetic Resonance Imaging
79. Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse
    Feng-Ju Huang, Weon‐Kyoo You, Paolo Bonaldo, Thomas N. Seyfried, Elena B. Pasquale, William B. Stallcup · 2010 · Developmental Biology
80. Age-related changes in the temporal and spatial distributions of fibrillin and elastin mRNAS and proteins in acute cutaneous wounds of healthy humans
    Gillian S. Ashcroft, Cay M. Kielty, M.A. Horan, Mark W. J. Ferguson · 1997 · The Journal of Pathology
81. The Rationale and Future Potential of Angiogenesis Inhibitors in Neoplasia
    Giampietro Gasparini · 1999 · Drugs
82. Expression of vascular endothelial growth factor (VEGF)‐C and VEGF‐D, and their receptor VEGFR‐3, during different stages of cervical carcinogenesis
    Philippe O Van Trappen, Dawn Steele, David G Lowe, Suhail I. Baithun, Nigel J P Beasley, Wilko Thiele, Herbert A. Weich, Jaya Krishnan, John H. Shepherd, Michael Sean Pepper et al. · 2003 · The Journal of Pathology
83. Expression of angiopoietins and its clinical significance in non-small cell lung cancer.
    Fumihiro Tanaka, Shinya Ishikawa, Kazuhiro Yanagihara, Ryo Miyahara, Yozo Kawano, Mio Li, Yosuke Otake, Hiromi Wada · 2002 · PubMed
84. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
    Barbro Kristina Linderholm, Thomas Lindahl, Lars Holmberg, Sigrid Klaar, Johan Lennerstrand, Roger Henriksson, Jonas C. S. Bergh · 2001 · PubMed
85. Cancer Prevention: From 1727 to Milestones of the Past 100 Years
    Scott Michael Lippman, Ernest T. Hawk · 2009 · Cancer Research
86. Genetic and hypoxic regulation of angiogenesis in gliomas
    Balveen Kaur, Chalet Tan, Daniel Jay Brat, Erwin G. Van Meir · 2004 · Journal of Neuro-Oncology
87. Microvessel density in prostate carcinoma
    Aldo Vittorio Bono, Nicola Celato, Vittoria Cova, Maurizio Salvadore, S Chinetti, Raffaele Novario · 2002 · Prostate Cancer and Prostatic Diseases
88. Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy
    Taturo Udagawa, António Fernández, Eike‐Gert Achilles, Judah Folkman, Robert J. D’Amato · 2002 · The FASEB Journal
89. Malignancy, thrombosis and Trousseau: the case for an eponym
    Alok A. Khorana · 2003 · Journal of Thrombosis and Haemostasis
90. Narrow band imaging with magnifying colonoscopy as diagnostic tool for predicting histology of early colorectal neoplasia
    Akiyoshi Katagiri, Kaiwu Fu, Yasushi Sano, Hiroaki Ikematsu, Takahiro Horimatsu, Kazuhiro Kaneko, Manabu Muto, Shigeo Yoshida · 2008 · Alimentary Pharmacology & Therapeutics
91. Characterization of adhesion molecules on human myeloma cell lines
    H Uchiyama, Bruce Barut, Dharminder Chauhan, SA Cannistra, Kenneth Carl Anderson · 1992 · Blood
92. First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer
    Martijn Smeenge, FF Tranquart, Christophe K. Mannaerts, Theo M. de Reijke, Marc J. van de Vijver, Maria Pilar Laguna, Sibylle Pochon, Jean J.M.C.H. de la Rosette, Hessel Wijkstra · 2017 · Investigative Radiology
93. Abbreviated Magnetic Resonance Imaging (MRI) for Breast Cancer Screening: Rationale, Concept, and Transfer to Clinical Practice
    Christiane Katharina Kuhl · 2019 · Annual Review of Medicine
94. Tumour dormancy: findings and hypotheses from clinical research on breast cancer
    Romano Demicheli · 2001 · Seminars in Cancer Biology
95. Inhibition of constitutive NF-κB activity by IκBαM suppresses tumorigenesis
    Shuichi Fujioka, Guido M. Sclabas, Christian Schmidt, Jiangong Niu, Wayne Frederick, Qiang G Dong, James L. Abbruzzese, Douglas B. Evans, Cheryl Hunt Baker, Paul J. Chiao · 2003 · Oncogene
96. Islet Microvasculature in Islet Hyperplasia and Failure in a Model of Type 2 Diabetes
    Xianquan Li, Lanjing Zhang, Sasha Meshinchi, Claudia L. Dias-Leme, Diane Raffin, Jeffery D. Johnson, Mary Kay Treutelaar, Charles Burant · 2006 · Diabetes
97. Induction of angiogenesis by normal and malignant plasma cells
    Dirk Hose, Jérôme Moreaux, Tobias Meißner, Anja Seckinger, Hartmut Goldschmidt, Axel Benner, Karène Mahtouk, Jens Hillengaß, Thierry X. Reme, John De Vos et al. · 2009 · Blood
98. Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis
    John Strugar, David Rothbart, William Harrington, Gregory R. Criscuolo · 1994 · Journal of neurosurgery
99. Amplification of fgfr4 gene in human breast and gynecological cancers
    Susanna Jaakkola, Paula Salmikangas, Stella J. Nylund, Pentti Lehtovirta, Heli A. Nevanlinna, Juha M. Partanen, Elina Armstrong, Seppo O Pyrhönen · 1993 · International Journal of Cancer
100. Role of tumor vascular architecture in drug delivery
     Ajit S. Narang, Sailesh A. Varia · 2011 · Advanced Drug Delivery Reviews